Navigation Links
Researchers urge caution in using ear tube surgery

Placing ear tubes in young children who develop fluid in the ears does not improve speech, hearing or psychological development, according to new research.

Currently there are two reasons for ear tube surgery -- persistent, severe ear infections and liquid in the inner ear cavity of an otherwise healthy child. Doctors have been concerned that if surgery is not used in the second case, children could face long-term developmental impairment.

"We were led to the conclusion that ear disease does not cause any developmental problems," said Dr. Jack Paradise, University of Pittsburgh School of Medicine and lead researcher of the study, which appears in the New England Journal of Medicine.

Researchers assessed speech, language and cognitive and psychological development in children at age 3 who had experienced persistent fluid in the ears during infancy and very early childhood. In the study, children either got ear tubes immediately, or researchers waited up to nine months to do the procedure if the ear fluid persisted. In the group where doctors waited, one-third of the children eventually got ear tubes.

"To many doctors this will come as a surprise because it's been a matter of some controversy and speculation and some doctors are convinced it's a problem," said Paradise. There's been a perception that children with liquid in the ear have impaired hearing, which could impact language and neurological development.

"Two and 3-year-old children are learning sounds and words and we wonder if some children are going around hearing muffled sounds," said Dr. James Perrin, with MassGeneral Hospital for Children and author of an editorial accompanying the study in the New England Journal of Medicine. "It's hard to measure hearing in these children, and we wonder 'does it sound muffled?' -- 'does it sound different?'"

Ear fluid build-up is about as common as ear infection. Children with persistent ear fluid may not have sympt
'"/>




Page: 1 2 3

Related medicine news :

1. Researchers Scale to assess the Severity of Epilepsy in Kids
2. Researchers trick Alzheimers Enzyme
3. Researchers find new HIV hiding place
4. New Hair in 15 Days Could Now Be A Possibility Say Researchers
5. Researchers developed world’s smallest toothbrus
6. Researchers discover receptor cells that can cause epilepsy
7. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
8. Researchers reversed the process of memory loss
9. Researchers Identify Key Gene That May Help Brain Treatment
10. Researchers Discover Protein That Causes Malaria
11. Commercialization of Biotech Discoveries, An Encouragement For Researchers
Post Your Comments:
(Date:5/16/2008)... Workers, WASHINGTON, May 16 /PRNewswire-USNewswi...cal technicians in the Greater Portland, Oregon an...irst-ever contract as,Teamsters., "The Teamsters ...a,strong contract that gives them job protection a...eral President Jim Hoffa., The workers, both full...
(Date:5/16/2008)... multicenter Phase III clinical trial has found th...AD001) significantly delays cancer progression in ...se had worsened on other treatments. The study wa... at Memorial Sloan-Kettering Cancer Center (MSKCC)...nnual meeting of the American Society for Clinical...
(Date:5/16/2008)...imary care medicine is in a precipitous decline, D...College of Physicians (ACP), today joined with le...o issue a call for comprehensive reforms to attrac... primary care physicians. , During a panel disc...e U.S., Dr. Dale and other panelists spoke about t...
(Date:5/16/2008)...ewswire-USNewswire/- "Huh, what did you,say?" is a...ularly our,children. More than 30 million American...aring loss and the numbers are growing at a dramat...dren have some form of hearing,loss. An effort to ...roblem,is what led Kathlyn Maguire, who has profou...
Breaking Medicine News(10 mins):Health News:Drug fends off kidney cancer progression 2Health News:ACP says major system reforms needed to improve the state of primary care medicine in the US 2Health News:Huh, What Did You Say?: May is 'Better Hearing and Speech Month' 2Health News:Huh, What Did You Say?: May is 'Better Hearing and Speech Month' 3
...out teenagers with eating disorders can do much da...iversity. // The December issue of the journal, Pe...onducted by the researchers from California. More ... surf websites that offer solutions for all kinds ...
...monkeys shows that ,limiting calorie intake may ac... input seems to improve the functioning of importa...nkeys are said to be closely akin to human beings ...hese findings reflect that a reduction in calorie ...
...ation clinic no. 17,faced one of the most deadlies...he last three decades //. 45 women were killed bec...se who died were young addicts below the age of 35...d from severe psychological disorders. Fire insp...
...reaks of the deadly Ebola virus in Africa have bee...hs in nearby forests. //Hotly debated has been whe... or part of a massive die-off. New research publis...st, providing strong evidence that Ebola killed at...
Other Medicine News:Health News:Ebola-Outbreak Kills 5000 Gorillas 2Health News:Ebola-Outbreak Kills 5000 Gorillas 3
(Date:5/16/2008)... Results demonstrating that TYKERB and trastuzumab...nsion of progression-free survival (PFS), -- Comb...side and,outside of the HER2 receptor may create a...ng activity of TYKERB alone despite patients,prev...and chemotherapy, LONDON and PHILADELPHIA, May 16...
(Date:5/16/2008)...Biomarkers -- for Lung Cancer Diagnosis and, Ident...of Unknown Primary ...pes With High Sensitivity and, Specificity and C...er Results of microRNA Signature to Identify Tiss...ng 90% and Specificity of 99%, REHOVOT, Israel an...
(Date:5/16/2008)... Mechanism May Offer Novel Approach to Blood ...ANS, May 16 /- Pharmacopeia... development of novel small,molecule therapeutics,...,Dual Acting Receptor Antagonist (DARA), showed st...in a Phase 2a study in patients with mild to,moder...
(Date:5/15/2008)...icacy for Population Most Affected by Disease -, ...wire-FirstCall/ --,Bayer HealthCare Pharmaceutical...NXX ) today announced that Nexavar(R) (sorafenib) ... 47.3 percent (HR=0.68;,p-value=0.014) in patients...llular carcinoma (HCC), or primary liver cancer ve...
Breaking Medicine Technology:GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 2GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 3GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 4GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 5GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 6GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 7Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 2Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 3Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 4Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 5Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 6Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 2Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 3Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 4Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 5Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 6Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 7Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 8Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6New Technology Improves the Appearance of Cellulite in a Single Treatment 15215 1New Technology Improves the Appearance of Cellulite in a Single Treatment 15215 2New Technology Improves the Appearance of Cellulite in a Single Treatment 15215 3Democrat Mike Turner Backs Single Payer Healthcare 3B Opponent Feder Undecided 15211 1Democrat Mike Turner Backs Single Payer Healthcare 3B Opponent Feder Undecided 15211 2NCPA Statement on Californias Delay of E Pedigree Implementation 15207 1NCPA Statement on Californias Delay of E Pedigree Implementation 15207 2Large multicenter study suggests new genetic markers for Crohns disease 15204 1Large multicenter study suggests new genetic markers for Crohns disease 15204 2
Shandon Carousel Cassette MicroWriter™ is a carousel-type cassette marking system.
Fully modular system for long-term storage. Available as complete five-drawer system or as individual components.
Store microscope slides with ease, speed, efficiency.
High-quality, epoxy-coated, stackable steel cabinets for the storage of microscope slides, slide filing wallets, processing cassettes, tissue blocks, transparencies and A5 index cards.
Medicine Products: